Carbocyclodipeptides as modified nucleosides: synthesis and anti-HIV activities

被引:1
|
作者
Chhikara, Bhupender S. [1 ]
Rao, M. Sudershan [2 ]
Rao, V. Kameshwara [2 ]
Kumar, Anil [2 ]
Buckheit, Karen W. [3 ]
Buckheit, Robert W., Jr. [3 ]
Parang, Keykavous [1 ,2 ,4 ]
机构
[1] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Coll Pharm, Kingston, RI 02881 USA
[2] Birla Inst Technol & Sci, Dept Chem, Pilani 333031, Rajasthan, India
[3] ImQuest BioSci Inc, Frederick, MD 21704 USA
[4] Chapman Univ, Sch Pharm, Irvine, CA 92618 USA
基金
美国国家卫生研究院;
关键词
anti-HIV; carbopeptides; cyclodipeptide; nucleoside analogues; 2 '-deoxyribofuranosyl; CELLULAR UPTAKE; ANALOGS; PRODRUGS; CYCLODIPEPTIDES; DERIVATIVES; INHIBITION;
D O I
10.1139/cjc-2014-0356
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A new class of nucleoside analogues were synthesized using cyclic dipeptides and modified 2'-deoxyfuranoribose sugars to introduce flexibility by peptides in place of common nucleoside bases and to determine their biological properties. The synthesis was carried out by coupling of a protected ribose sugar with synthesized dipeptides in the presence of hexamethyldisilazane and trimethylsilyltriflate. The final products were characterized by NMR and high-resolution MS-TOF spectroscopy. The compounds were evaluated for anti-HIV activities. 1-(4-Azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,6-diisopropylpiperazine2,5-dione (compound 14) containing 3- and 6-isopropyl groups in the base and 3'-azide (EC50 = 1.96 mu mol/L) was the most potent compound among all of the synthesized analogs.
引用
收藏
页码:1145 / 1149
页数:5
相关论文
共 50 条
  • [1] Bis(cycloSaligenyl) derivatives of nucleosides: Synthesis and anti-HIV activities
    Ahmadibeni, Yousef
    Tiwari, Rakesh
    Doncel, Gustavo F.
    Parang, Keykavous
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [2] Synthesis and anti-HIV activity of dihydroisoxazole nucleosides
    Gi, HJ
    Xiang, YJ
    Schinazi, RF
    Zhao, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 29 - MEDI
  • [3] Synthesis and anti-HIV activity of C4-modified pyrimidine nucleosides
    Wallis, MP
    Mahmood, N
    Fraser, W
    FARMACO, 1999, 54 (1-2): : 83 - 89
  • [4] Synthesis and Anti-HIV Evaluation of 3'-Triazolo Nucleosides
    Roy, Vincent
    Obikhod, Aleksandr
    Zhang, Hong-Wang
    Coats, Steven J.
    Herman, Brian D.
    Sluis-Cremer, Nicolas
    Agrofoglio, Luigi A.
    Schinazi, Raymond F.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2011, 30 (04): : 264 - 270
  • [5] THE SYNTHESIS AND ANTI-HIV ACTIVITY OF PYRIMIDINE DIOXOLANYL NUCLEOSIDES
    WILSON, LJ
    CHOI, WB
    SPURLING, T
    LIOTTA, DC
    SCHINAZI, RF
    CANNON, D
    PAINTER, GR
    STCLAIR, M
    FURMAN, PA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (02) : 169 - 174
  • [6] SYNTHESIS AND ANTI-HIV ACTIVITY OF DIFFERENT SUGAR-MODIFIED PYRIMIDINE AND PURINE NUCLEOSIDES
    HERDEWIJN, P
    BALZARINI, J
    BABA, M
    PAUWELS, R
    VANAERSCHOT, A
    JANSSEN, G
    DECLERCQ, E
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (10) : 2040 - 2048
  • [7] SYNTHESIS AND ANTI-HIV ACTIVITY OF 4′-MODIFIED CYCLOPENTENYL PYRIMIDINE C-NUCLEOSIDES
    Liu, Lian Jin
    Hong, Joon Hee
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2009, 28 (04): : 303 - 314
  • [8] SYNTHESIS OF OPTICALLY PURE DIOXOLANE NUCLEOSIDES AND THEIR ANTI-HIV ACTIVITY
    SIDDIQUI, MA
    EVANS, C
    JIN, HL
    TSE, A
    BROWN, W
    NGUYENBA, N
    MANSOUR, TS
    CAMERON, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 51 - MEDI
  • [9] Synthesis and anti-HIV activity of different novel nonclassical nucleosides
    Elgemeie, GEH
    Mansour, OA
    Metwally, NH
    NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (01): : 113 - 123
  • [10] Synthesis and anti-HIV activities of phorbol derivatives
    HUANG Xiaolei
    TANG Chengrun
    HUANG Xusheng
    YANG Yun
    LI Qirun
    MA Mengdi
    ZHAO Lei
    YANG Liumeng
    CUI Yadong
    ZHANG Zhenqing
    ZHENG Yongtang
    ZHANG Jian
    Chinese Journal of Natural Medicines, 2024, 22 (02) : 146 - 160